TSO3 Inc. (TSE:TOS) – Stock analysts at National Bank Financial raised their FY2018 EPS estimates for shares of TSO3 in a report issued on Wednesday, November 7th. National Bank Financial analyst E. Leno now anticipates that the company will post earnings per share of ($0.20) for the year, up from their previous estimate of ($0.22). National Bank Financial has a “Sector Perform” rating and a $1.25 price objective on the stock.

A number of other equities analysts also recently weighed in on the company. Royal Bank of Canada dropped their target price on TSO3 from C$0.90 to C$0.80 and set a “sector perform” rating on the stock in a report on Thursday, November 8th. Desjardins dropped their target price on TSO3 from C$1.25 to C$1.10 in a report on Thursday, August 9th. Four equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus price target of C$1.58.

Shares of TOS opened at C$0.47 on Monday. TSO3 has a fifty-two week low of C$0.39 and a fifty-two week high of C$2.83. The company has a debt-to-equity ratio of 415.90, a current ratio of 9.07 and a quick ratio of 7.26.

TSO3 Company Profile

TSO3 Inc engages in the research, development, production, maintenance, sale, and licensing of sterilization processes, related consumable supplies, and accessories for heat and moisture sensitive medical devices worldwide. Its principal product is the STERIZONE VP4 sterilizer, a dual sterilant, low temperature sterilization system that utilizes vaporized hydrogen peroxide and ozone that is marketed in Canada and the United States.

Featured Story: Book Value Of Equity Per Share – BVPS Explained

Earnings History and Estimates for TSO3 (TSE:TOS)

Receive News & Ratings for TSO3 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TSO3 and related companies with MarketBeat.com's FREE daily email newsletter.